Valeant Raises Bid for Allergan to $49.4 Billion

Valeant Pharmaceuticals raised its offer to buy Botox maker Allergan, increasing the cash portion of its bid and lifting its overall value to more than $49 billion.



from WSJ.com: US Business http://ift.tt/1nU7dfq

via IFTTT